Journals / Çocuk Enfeksiyon Dergisi / 2014 / Cilt: 8 - Sayı: 2

Akut lösemi tanılı bir hastada fungal dilate kardiyomiyopati, nasıl tedavi etmeli?

Fungal dilated cardiomyopathy in a patient with acute leukemia, how to treat?

Pages
82–85
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, a rare case of dilated cardiomyopathy and endocarditis due to Candida albicans in a 4-year-old child diagnosed with acute lymphoblastic leukemia is shared and its treatment is discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Candida infection is an uncommon cause of myocar- ditis, endocarditis and dilated cardiomyopathy.
📊
Key Findings & Data:It is well-known that the initiation time of antifungal treat- ment in these patients affects mortality rates.
💡
Conclusion & Impact:In this report, a rare case of dilated cardiomyopathy and endocarditis due to Candida albicans in a 4-year-old child diagnosed with acute lymphoblastic leukemia is shared and its treatment is discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Candida infection is an uncommon cause of myocar- ditis, endocarditis and dilated cardiomyopathy. It is well-known that the initiation time of antifungal treat- ment in these patients affects mortality rates. The optimal antifungal choice and duration of treatment for cardiac Candida infection is not yet well defined. In this report, a rare case of dilated cardiomyopathy and endocarditis due to Candida albicans in a 4-year-old child diagnosed with acute lymphoblastic leukemia is shared and its treatment is discussed.

Özet

Candida enfeksiyonu myokardit, endokardit ve dilate kardiyomyopatinin nadir bir sebebidir. Antifungal teda- vinin başlanma zamanın bu hastalarda mortalite oran- larını etkilediği iyi bilinmektedir. Kardiyak Candida enfeksiyonlarındaki optimal antifungal seçeneği ve tedavi süresi ise henüz kesin olarak tanımlanmamıştır. Bu çalışmada akut lenfoblastik lösemi tanılı dört yaşın- daki bir çocukta Candida albicansa bağlı nadir bir dilate kardiyomiyopati ve endokardit vakası paylaşıla- rak tedavisi tartışıldı.

🔖

Cite This Article

AYHAN, A. C., AYHAN, Y., TİMUR, Ç., ERGÜVEN, M. (2014). Akut lösemi tanılı bir hastada fungal dilate kardiyomiyopati, nasıl tedavi etmeli?. Çocuk Enfeksiyon Dergisi, Cilt: 8 - Sayı: 2, 82–85. https://ajindex.com/articles/196029

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Falcone M, Barzaghi N, Carosi G, et al. Candida infective endocarditis. Medicine 2009; 88: 160-8. [CrossRef] 2. Nosanchuk JD. Fungal myocarditis. Frontiers in Bioscience 2002; 7: 1423-38. [CrossRef] 3. Li JS, Sexton DJ, Mick N, et al.Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-8. [CrossRef] 4. Ruping MJ, Vehreschild JJ, Cornely OA. Patients at high risk of invasive fungal infections: when and how treat. Drugs 2008; 68: 1941-62. [CrossRef] 5. Pierrotti LC, Baddour LM. Fungal endocarditics. Chest.2002; 122: 302-10. [CrossRef] 6. Rubinstein E, Noriega E, Simbekoff M, et al. Fungal endocardi- tis: analysis of 24 cases and review of the literature. Medicine 1975; 54: 331-4. 7. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 8: 503-35. [CrossRef] 8. Wang H, Xiao M, Chen SC, et al. In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study. J Clin Microbiol 2012; 50: 3952-9. [CrossRef] 9. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on preventa- tion, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 2004 Feb; 25: 267-76. [CrossRef] 10. Danaher PJ, Cao MK, Anstead GM, et al. Reversible dilated cardiomyopathy related to amphotericin B therapy. J Antimicrob Chemother 2004; 53: 115-7. [CrossRef] 11. Bacak V, Biocina B, Starcevic B, et al. Candida albicans endocar- ditis treatment with caspofungin in an HIV-infected patient-case report and review of literature. J Infect 2006; 53: 11-4. [CrossRef] 12. Rajendram R, Alp NJ, Mitchell AR, et al. Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement. Clin Infect Dis 2005; 40: 72-4. [CrossRef] 13. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-60. [CrossRef]